Some people infected with HIV are teeming with virus, but don’t get sick. Their resistive powers probably come from a mix of ...

Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...

On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new results from a Phase 2 clinical ...

A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

Health authorities in Rio de Janeiro are reviewing samples from 288 donors after discovering that two HIV-positive people ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

The following is a summary of “Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the ...

Among recipients with HIV, kidney transplantation from donors with HIV is noninferior to that from donors without HIV.

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

Uganda's efforts to combat the HIV/AIDS epidemic have made significant strides, yet crucial gaps remain, particularly in preventing mother-to-child transmission of the virus.